Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098133864> ?p ?o ?g. }
- W2098133864 endingPage "41076" @default.
- W2098133864 startingPage "41063" @default.
- W2098133864 abstract "Ephrin receptor A4 (EphA4) is overexpressed in human pancreatic adenocarcinoma (PDAC) and activate cell growth. Recent studies have identified small molecules that block EphA4. In this study, we investigated the correlation between EphA4 expression and the prognosis of patients with PDAC. We also examined the cytostatic efficacy of 2,5-dimethylpyrrolyl benzoic acid (compound 1), a small molecule that blocks EphA4, in PDAC cells. Overall survival of patients with EphA4 positivity was significantly shorter than that of patients with EphA4 negativity (P = 0.029). In addition, multivariate analysis revealed that EphA4 expression was an independent prognostic factor in PDAC patients (P = 0.039). Compound 1 showed a cytostatic efficacy in PDAC cells expressing EphA4 in vitro and in vivo. Our study indicated that compound 1 suppressed both EphA4 and Akt phosphorylations, and induced apoptosis in PDAC cells expressing EphA4. In conclusion, compound 1 has a high potential as a therapeutic agent for patients with PDAC." @default.
- W2098133864 created "2016-06-24" @default.
- W2098133864 creator A5028816789 @default.
- W2098133864 creator A5031482885 @default.
- W2098133864 creator A5033954724 @default.
- W2098133864 creator A5036975538 @default.
- W2098133864 creator A5037472971 @default.
- W2098133864 creator A5051002709 @default.
- W2098133864 creator A5052504412 @default.
- W2098133864 creator A5054053950 @default.
- W2098133864 creator A5055390095 @default.
- W2098133864 creator A5059067160 @default.
- W2098133864 creator A5060744842 @default.
- W2098133864 creator A5067361570 @default.
- W2098133864 creator A5090382073 @default.
- W2098133864 creator A5090915905 @default.
- W2098133864 creator A5091879693 @default.
- W2098133864 date "2015-10-19" @default.
- W2098133864 modified "2023-09-27" @default.
- W2098133864 title "Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice" @default.
- W2098133864 cites W1597741096 @default.
- W2098133864 cites W1968812902 @default.
- W2098133864 cites W1969404579 @default.
- W2098133864 cites W1970200165 @default.
- W2098133864 cites W1974208182 @default.
- W2098133864 cites W1979224825 @default.
- W2098133864 cites W1980739005 @default.
- W2098133864 cites W1987750014 @default.
- W2098133864 cites W1992187858 @default.
- W2098133864 cites W1993354361 @default.
- W2098133864 cites W1997670728 @default.
- W2098133864 cites W2005539952 @default.
- W2098133864 cites W2005611806 @default.
- W2098133864 cites W2006102680 @default.
- W2098133864 cites W2007904375 @default.
- W2098133864 cites W2008227389 @default.
- W2098133864 cites W2010250857 @default.
- W2098133864 cites W2010955929 @default.
- W2098133864 cites W2017292900 @default.
- W2098133864 cites W2020457650 @default.
- W2098133864 cites W2033124377 @default.
- W2098133864 cites W2036519126 @default.
- W2098133864 cites W2038894508 @default.
- W2098133864 cites W2041353243 @default.
- W2098133864 cites W2064781878 @default.
- W2098133864 cites W2071500602 @default.
- W2098133864 cites W2080510309 @default.
- W2098133864 cites W2088023367 @default.
- W2098133864 cites W2096440150 @default.
- W2098133864 cites W2097767970 @default.
- W2098133864 cites W2103459879 @default.
- W2098133864 cites W2108078129 @default.
- W2098133864 cites W2110110458 @default.
- W2098133864 cites W2120376007 @default.
- W2098133864 cites W2122303778 @default.
- W2098133864 cites W2132097639 @default.
- W2098133864 cites W2133774870 @default.
- W2098133864 cites W2139429540 @default.
- W2098133864 cites W2147114673 @default.
- W2098133864 cites W2147368820 @default.
- W2098133864 cites W2151253787 @default.
- W2098133864 cites W2153079609 @default.
- W2098133864 cites W2161934710 @default.
- W2098133864 cites W2165480504 @default.
- W2098133864 cites W2169194081 @default.
- W2098133864 cites W2169961966 @default.
- W2098133864 cites W2219978888 @default.
- W2098133864 cites W2276797565 @default.
- W2098133864 cites W4231031590 @default.
- W2098133864 doi "https://doi.org/10.18632/oncotarget.5729" @default.
- W2098133864 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4747390" @default.
- W2098133864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26516928" @default.
- W2098133864 hasPublicationYear "2015" @default.
- W2098133864 type Work @default.
- W2098133864 sameAs 2098133864 @default.
- W2098133864 citedByCount "15" @default.
- W2098133864 countsByYear W20981338642016 @default.
- W2098133864 countsByYear W20981338642017 @default.
- W2098133864 countsByYear W20981338642018 @default.
- W2098133864 countsByYear W20981338642019 @default.
- W2098133864 countsByYear W20981338642020 @default.
- W2098133864 countsByYear W20981338642021 @default.
- W2098133864 countsByYear W20981338642022 @default.
- W2098133864 countsByYear W20981338642023 @default.
- W2098133864 crossrefType "journal-article" @default.
- W2098133864 hasAuthorship W2098133864A5028816789 @default.
- W2098133864 hasAuthorship W2098133864A5031482885 @default.
- W2098133864 hasAuthorship W2098133864A5033954724 @default.
- W2098133864 hasAuthorship W2098133864A5036975538 @default.
- W2098133864 hasAuthorship W2098133864A5037472971 @default.
- W2098133864 hasAuthorship W2098133864A5051002709 @default.
- W2098133864 hasAuthorship W2098133864A5052504412 @default.
- W2098133864 hasAuthorship W2098133864A5054053950 @default.
- W2098133864 hasAuthorship W2098133864A5055390095 @default.
- W2098133864 hasAuthorship W2098133864A5059067160 @default.
- W2098133864 hasAuthorship W2098133864A5060744842 @default.
- W2098133864 hasAuthorship W2098133864A5067361570 @default.
- W2098133864 hasAuthorship W2098133864A5090382073 @default.